ÑÇÖÞ×ÔοÊÓƵ

Kathryn A. Maurer
( out of 172 reviews )

Kathryn A. Maurer, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
Salt Lake City
801-213-4269

Intermountain Medical Center- Women & Newborn

ÑÇÖÞ×ÔοÊÓƵ ÑÇÖÞ×ÔοÊÓƵ Specialty Gynecology
Murray
801-587-2809

  • Dr. Kathryn Maurer provides patients with the treatment and management of gynecologic cancers. This includes ovarian, endometrial, cervical, and vulvar cancers, employing both traditional and minimally invasive techniques. She specializes in the minimally invasive management of gynecologic malignancies, comprehensive gynecologic cancer screening, and the evaluation and management of hereditary gynecologic cancer syndromes. Through clinical trials, she is committed to the advancement of the treatment of these cancers.

    Dr. Maurer is currently accepting new patients on a referral basis. For more information, please call the women’s health services at 801-213-2995.

    Dr. Maurer earned her Sc.B. in Geology and Biology from Brown ÑÇÖÞ×ÔοÊÓƵ and her Medical Degree from the ÑÇÖÞ×ÔοÊÓƵ of Michigan Medical School. She completed her residency in Obstetrics and Gynecology at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine, followed by a fellowship in Gynecologic Oncology at the Cleveland Clinic in Ohio. She is board-certified in Obstetrics and Gynecology, with a subspecialty certification in Gynecologic Oncology from the American Board of Obstetrics & Gynecology.

    Her academic role is as a Gynecologic Oncologist and Assistant Professor at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine and the Huntsman Cancer Institute. Dr. Maurer educates the next generation of medical professionals. Her clinical practice at the Huntsman Cancer Institute is focused on providing exceptional care and improving outcomes for patients with gynecologic cancers. is a gynecologic oncologist and assistant professor at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine and the Huntsman Cancer Institute.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)

    Patient Rating

    4.9 /5
    ( out of 172 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    May 07, 2025
    HUNTSMAN CANCER CENTER

    Dr. Maurer is an extremely gifted surgeon. Not only is her technique outstanding, she is extremely knowledgeable and personable.

    April 29, 2025
    HUNTSMAN CANCER CENTER

    Hands-down, one of the best interactions with a doctor I've ever had. She's friendly, listens intently, thorough, and answers all questions. She cares about you as a person. She's a great surgeon.

    April 24, 2025
    HUNTSMAN CANCER CENTER

    She is awesome. I was and still am scard about cancer and what happens and she is not only brilliant but she explains all so well. I am so lucky I found her.

    April 23, 2025
    HUNTSMAN CANCER CENTER

    Dr. Maurer is an excellent physician. She is personable and professional.

    April 08, 2025
    HUNTSMAN CANCER CENTER

    Dr. Maurer and her staff explain and give me the best care. I have complete confidence in the care they give me.

    March 27, 2025
    HUNTSMAN CANCER CENTER

    Dr.Maurer invites collaborative discussion in your care. That is/ was critical for me to validate my own role as head of my ÑÇÖÞ×ÔοÊÓƵcare team. Cannot say enough about how important is has been for a physician to listen and hear me.

    March 26, 2025
    HUNTSMAN CANCER CENTER

    Very honest and compassionate

    March 12, 2025
    HUNTSMAN CANCER CENTER

    Dr. Maureen is so compassionate and caring each time I have seen her for the past 5 years. She always helps me with any medical issues that I have.

    February 26, 2025
    HUNTSMAN CANCER CENTER

    She is the best!

    See More Patient Comments

  • Dr. Kathryn Maurer provides patients with the treatment and management of gynecologic cancers. This includes ovarian, endometrial, cervical, and vulvar cancers, employing both traditional and minimally invasive techniques. She specializes in the minimally invasive management of gynecologic malignancies, comprehensive gynecologic cancer screening, and the evaluation and management of hereditary gynecologic cancer syndromes. Through clinical trials, she is committed to the advancement of the treatment of these cancers.

    Dr. Maurer is currently accepting new patients on a referral basis. For more information, please call the women’s health services at 801-213-2995.

    Dr. Maurer earned her Sc.B. in Geology and Biology from Brown ÑÇÖÞ×ÔοÊÓƵ and her Medical Degree from the ÑÇÖÞ×ÔοÊÓƵ of Michigan Medical School. She completed her residency in Obstetrics and Gynecology at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine, followed by a fellowship in Gynecologic Oncology at the Cleveland Clinic in Ohio. She is board-certified in Obstetrics and Gynecology, with a subspecialty certification in Gynecologic Oncology from the American Board of Obstetrics & Gynecology.

    Her academic role is as a Gynecologic Oncologist and Assistant Professor at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine and the Huntsman Cancer Institute. Dr. Maurer educates the next generation of medical professionals. Her clinical practice at the Huntsman Cancer Institute is focused on providing exceptional care and improving outcomes for patients with gynecologic cancers. is a gynecologic oncologist and assistant professor at the ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine and the Huntsman Cancer Institute.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Assistant Professor (Clinical)
    Academic Divisions Gynecological Oncology
    Board Certification
    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)

    Education history

    Fellowship Gynecologic Oncology - Cleveland Clinic Fellow
    Residency Obstetrics and Gynecology - ÑÇÖÞ×ÔοÊÓƵ of Utah School of Medicine Resident
    Professional Medical Medicine - ÑÇÖÞ×ÔοÊÓƵ of Michigan Medical School M.D.
    Undergraduate Geology, Biology - Brown ÑÇÖÞ×ÔοÊÓƵ Sc.B.

    Selected Publications

    Journal Article

    1. Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2025). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. ()
    2. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. ()
    3. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. ()
    4. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol, 162(2), 454-460. ()
    5. Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. ()
    6. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. ()
    7. McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. ()
    8. Rodriguez AC, Blanchard Z, Maurer KA, Gertz J (2019). Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer, 10(2-3), 51-63. ()
    9. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. ()
    10. Maurer K, Michener C, Mahdi H, Rose PG (2016). Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. J Gynecol Oncol, 28(4), e38. ()

    Case Report

    1. Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. ()